Zivimox-LP Eye Drops 5 ml

babies: safe if prescribed. lactating mothers: there is no information on whether loteprednol etabonate is excreted in human milk. therefore consult your doctor before use. pregnancy: there are no clinical data on exposed pregnancies for loteprednol etabonate & moxifloxacin hcl eye drops.
animal studies have revealed reproductive toxicity loteprednol etabonate and moxifloxacin hcl eye drops potential risk to humans is unknown, and it should not be used during pregnancy unless necessary. driving: loteprednol etabonate and moxifloxacin hcl eye drops may cause temporary blurring of your vision after use. do not drive until you have clear vision. alcohol: loteprednol etabonate and moxifloxacin hcl eye drops do not interact with alcohol kidney: loteprednol etabonate and moxifloxacin hcl eye drops is safe if prescribed by your doctor in patients with kidney disease. liver: loteprednol etabonate and moxifloxacin hcl eye drops is safe if prescribed by your doctor in patients with liver disease..

Eye swelling Eye irritation Eye discomfort Headache Blurred vision Increased intraocular pressure .

ZIVIMOX LP eye drops is an ophthalmologic agent and antibiotic. it is a combination of three medicines.
it is a combination of two medications. loteprednol etabonate is a steroid that inhibits the production of chemical messengers (prostaglandins) that cause the eyes to become red, swollen, and itchy.
moxifloxacin is an antibiotic that inhibits bacterial cell division and repair, killing the bacteria. this medication also takes care of your eye infection and inflammation..

If you miss a dose of ZIVIMOX LP eye drops, apply the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not apply a double amount to make up for a missed one..

• ZIVIMOX LP eye drops are used to treat bacterial infections and eye inflammation. • even if you feel better, do not skip any doses and complete the entire course of treatment.
stopping it too soon may cause the infection to resurface and become more challenging to treat. • to avoid contamination, do not touch the tip to any surface.
• to avoid dilution, wait at least 5-10 minutes before administering the following medication. • when first used, it may cause temporary blurring of vision.
when driving or operating machinery, exercise extreme caution. • wearing contact lenses is not recommended until your infection has cleared up.
• do not use it more frequently or for a more extended period than your doctor has prescribed. if your condition hasn't improved after two weeks, consult your doctor..

contraindicated • (loteprednol etabonate + moxifloxacin hcl) + desmopressin: concurrent use may lead to increased risk of severe hyponatremia serious • (loteprednol etabonate + moxifloxacin hcl) + bemiparin + concurrent use may lead to increased risk of bleeding • (loteprednol etabonate + moxifloxacin hcl) + macimorelin: concurrent use may lead to fast positive or fast negative adult growth hormone deficiency diagnosis • (loteprednol etabonate + moxifloxacin hcl) + nadroparin: concurrent use may lead to increased risk of bleeding • (loteprednol etabonate + moxifloxacin hcl) + sargramostim: concurrent use may lead to increased myeloproliferative effects of sargramostim monitor closely • (loteprednol etabonate + moxifloxacin hcl) + auranofin: concurrent use may lead to increased risk of auranofin related adverse effects • (loteprednol etabonate + moxifloxacin hcl) + glycerol phenylbutyrate: concurrent use may lead to increased plasma ammonia levels • (loteprednol etabonate + moxifloxacin hcl) + testosterone: concurrent use may lead to increased risk of oedema.